THOR Synthorx Inc

Thoratec Presentation at Lehman Brothers Conference Available Via Webcast PLEASANTON, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in products to treat cardiovascular disease, said today it will be participating inthe Lehman Brothers Seventh Annual Global Healthcare Conference on Wednesday, March 3. D. Keith Grossman, president and chief executive officer, will present an update on the company beginning at 10:15 a.m., Eastern Standard Time. The presentation will be available via the Internet on the company's web site, http://www.thoratec.com/ or through the conference web site, http://www.lehman.com/conferences/200403Healthcare. Thoratec Corporation is a world leader in products to treat cardiovascular disease with its Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) implanted in more than 6,600 patients suffering from heart failure. Thoratec's product line also includes the Vectra(R) vascular access graft(VAG) for patients undergoing hemodialysis. Additionally, its International Technidyne Corporation (ITC) division supplies blood coagulation testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com/ or http://www.itcmed.com/ . DATASOURCE: Thoratec Corporation CONTACT: investors, Wayne Boylston, Chief Financial Officer, +1-925-847-8600, or media, Susan Benton of FischerHealth, Inc., +1-310-577-7870, or , both for Thoratec Corporation Web site: http://www.thoratec.com/

Copyright